Evidence map›Paper›PMID 24790834›Full record

ArticleBiomolecules2013

Overcoming challenges and opening new opportunities in glycoproteomics.

Ten-Yang Yen, Sucharita M Dutta, Christina Litsakos-Cheung, Alejandro A Corona, Leslie C Timpe, Bruce A Macher

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. A Quantitative Glycomics and Proteomics Combined Purification Strategy.Journal of visualized experiments : JoVE · 2016
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ten-Yang YenDepartment of Chemistry and Biochemistry, San Francisco State University, San Francisco, CA 94132, USA.
Sucharita M DuttaThermo Fisher Scientific, San Jose, CA 95134, USA; sucha227@gmail.com.
Christina Litsakos-CheungDepartment of Chemistry and Biochemistry, San Francisco State University, San Francisco, CA 94132, USA.
Alejandro A CoronaDepartment of Chemistry and Biochemistry, San Francisco State University, San Francisco, CA 94132, USA.
Leslie C TimpeDepartment of Chemistry and Biochemistry, San Francisco State University, San Francisco, CA 94132, USA.
Bruce A MacherDepartment of Chemistry and Biochemistry, San Francisco State University, San Francisco, CA 94132, USA.
San Francisco State University · USThermo Fisher Scientific (United States) · US

Funding

Student EnrichmentP20MD000544 · NIMHD · SAN FRANCISCO STATE UNIVERSITY · PI BAIRD, TEASTER T · 2003 to 2012
$9.4M
Glycoprotein Signatures as Biomarkers for Breast CancerR15CA164929 · NCI · SAN FRANCISCO STATE UNIVERSITY · PI MACHER, BRUCE A., TIMPE, LESLIE CHARLES · 2012 to 2012
$462k
NCI NIH HHS R15 CA164929NIMHD NIH HHS P20 MD000544
6 · The paper itself

Abstract

Glycoproteomics has emerged as a prime area of interest within the field of proteomics because glycoproteins have been shown to function as biomarkers for disease and as promising therapeutic targets. A significant challenge in the study of glycoproteins is the fact that they are expressed in relatively low abundance in cells. In response, various enrichment methods have been developed to improve the detection of glycoproteins. One such method involves their capture via oxidation of their glycan chains and covalent attachment with hydrazide resins which, when catalyzed by PNGase F, release N-linked glycans and convert the glycosite Asn to Asp; this conversion is identifiable with LC/ESI-MS/MS as a corresponding increase of 0.984 Da in molecular weight. The present study builds on this body of work, providing evidence of three additional strategies that improve glycoprotein identification: (1) use of a high resolution mass spectrometer-the Q Exactive MS-which delivers 2-3 times more glycoprotein identifications than a low resolution MS; (2) optimization of instrument settings and database search parameters to reduce misidentification of N-linked glycopeptides to ~1 percent; and (3) labeling glycopeptides with (18)O during PNGase F treatment to locate N-linked glycosites within peptides containing multiple N-linked sequons.

Indexed as

18O labelingdeamidationglycoproteomicshydrazide-modified magnetic beadsN-linked glycositesOrbitraptandem mass spectrometry

Identifiers

PMID24790834
PMCPMC4002168
OpenAlexW2140941182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.